national stem-cell therapy logo

Unlocking the Secrets of the Universe to Combat Neurodegenerative Diseases: NASA’s SpaceX CRS-30 Mission

NASA's SpaceX mission to Combat Neurodegenerative Diseases

In an unprecedented move towards understanding and potentially halting the progression of neurodegenerative diseases, NASA’s SpaceX CRS-30 Mission, in collaboration with the National Stem Cell Foundation, is set to launch its 6th investigation into the mysteries of these conditions. This mission marks a significant step forward in the fight against debilitating diseases like Alzheimer’s, Parkinson’s […]

Revolutionizing Parkinson’s Disease Treatment: TreeFrog Therapeutics’ Leap Forward

A man with Parkinson's sitting on a park bench

In the ever-evolving field of regenerative medicine, a significant milestone is on the horizon, courtesy of TreeFrog Therapeutics. At the 23rd Congress of the Japanese Society for Regenerative Medicine (JSRM) in Niigata, Japan, a presentation by Maxime Feyeux, the Chief Scientific Officer and Co-founder of TreeFrog, has sparked excitement and hope. TreeFrog Therapeutics, a frontrunner […]

Pioneering Neurodegenerative Disease Research with Stem Cell-Derived Brain Organoids in Space

ISS National Laboratory logo

The Groundbreaking Mission: In a significant leap towards understanding neurodegenerative disorders, the International Space Station National Lab is hosting an innovative research project. This project involves stem cell-derived brain organoids being sent to space as part of Axiom Space’s third private astronaut mission. The objective is to improve the modeling of diseases like Parkinson’s disease […]

Advances in Neuroprotective Strategies with Stem Cells

Neuroprotective Strategies using Stem Cell Therapy

In today’s ever-evolving world of medical research, we are witnessing a revolution in the field of neuroscience. With the increasing prevalence of neurological disorders and the need for effective interventions, neuroprotective strategies using stem cell therapy have emerged as a beacon of hope. Stem cells, with their unique regenerative capabilities, hold immense potential for the […]

Aspen Neuroscience Cofounder Dr. Andrés Bratt-Leal Receives 2023 Biocom California Life Science Catalyst Award

Aspen's Dr. Andres Bratt Leal

Dr. Andrés Bratt-Leal, co-founder and Senior Vice President of Research and Development at Aspen Neuroscience, has been honored with the prestigious 2023 Biocom California Life Science Catalyst Award. This accolade, presented by Biocom California, recognizes the most inspiring and driven young minds in the California life sciences industry who are making significant contributions to human […]

Embryonic Stem Cell Research for Neurodegenerative Diseases

illustration of the power of ESCs for neurodegenerative diseases

In the realm of medical science, few topics have sparked as much hope and controversy as stem cell therapy. These remarkable cells, with their unique ability to transform into various cell types, are a cornerstone of regenerative medicine. Among them, embryonic stem cells (ESCs) stand out due to their exceptional pluripotency. This article delves into […]

FDA Grants Fast Track Designation to ANPD001 for Parkinson’s Disease Treatment

Aspen Neuroscience Logo

Aspen Neuroscience, a clinical development-stage company, recently announced a significant milestone in the fight against Parkinson’s disease (PD). The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ANPD001, an autologous (personalized) investigational cell therapy designed to treat Parkinson’s disease by replacing lost dopamine neurons. This designation aims to accelerate the development […]

Rune Labs and Aspen Neuroscience Collaborate on Parkinson’s Disease Study

Rune Labs Logo

Rune Labs, a leading precision neurology software and data platform company, has joined forces with Aspen Neuroscience Inc., a prominent autologous cell therapy biotechnology firm. The collaboration aims to leverage Rune Labs’ StriveStudy clinical development platform, enabling Aspen to gather real-time, longitudinal patient data remotely. The primary objective of this partnership is to utilize the […]

Aspen’s Breakthrough FDA-Cleared Parkinson’s Cell Therapy Unveiled

Aspen Neuroscience Logo

Aspen Neuroscience has announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for ANPD001, an autologous cell therapy designed to treat Parkinson’s Disease (PD) by replacing lost dopamine neurons. The clearance enables Aspen to initiate a first-in-patient Phase 1/2a clinical trial for individuals with moderate to severe […]